We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Leprosy Vaccine Launches into Clinical Trials

News   Oct 13, 2017 | Original story from the Infectious Disease Research Institute (IDRI)

 
New Leprosy Vaccine Launches into Clinical Trials
 
 
Advertisement
 

RELATED ARTICLES

Exploiting the Antimicrobial Properties of Toadlet Peptide To Kill Bacteria

News

Researchers have uncovered specific molecular properties of an antimicrobial peptide from the skin of the Australian toadlet that could be exploited in efforts to develop novel synthetic drugs to combat bacterial infections.

READ MORE

Naltrexone–Bupropion Drug Combination May Help To Treat Methamphetamine Addiction

News

Combining the injectable drug naltrexone and a commonly prescribed antidepressant called bupropion was shown to produce positive results in 13.6 percent of 403 patients treated, significantly higher than the 2.5 percent response in placebo groups, in a study published in The New England Journal of Medicine.

READ MORE

Psychological Factors and the Immune Response to Vaccines

News

Ohio State University researchers reviewed 49 vaccine studies in humans dating back 30 years that document how stress, depression and poor health behaviors can negatively affect the body’s immune response to vaccination, and how improving health factors can enhance that response.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE